Home › Funds › Point72 Asset Management › SLN
Point72 Asset Management position in SLN
SILENCE THERAPEUTICS PLC · Health Care
Latest position (Q1 2026)119.71K sh
Reported value held$630.88K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 250.00K | $5.97M | New |
| Q1 2022 | 250.00K | $4.75M | Hold |
| Q2 2022 | 250.00K | $2.96M | Hold |
| Q3 2022 | 550.88K | $5.53M | Add |
| Q4 2022 | 370.56K | $5.65M | Reduce |
| Q1 2023 | 349.46K | $2.17M | Reduce |
| Q2 2023 | 86.70K | $476.85K | Reduce |
| Q1 2024 | 8.20K | $177.12K | New |
| Q2 2024 | 146.50K | $2.78M | Add |
| Q3 2024 | 467.80K | $8.50M | Add |
| Q4 2024 | 633.10K | $4.36M | Add |
| Q1 2025 | 16.03K | $45.21K | Reduce |
| Q1 2025 | 16.03K | $45.21K | Reduce |
| Q4 2025 | 114.07K | $693.55K | New |
| Q1 2026 | 119.71K | $630.88K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding SLN
- Citadel Advisors 1.33M sh · $14.60M · Q2 2026
- Millennium Management 909.28K sh · $9.98M · Q2 2026
- Balyasny Asset Management 610.98K sh · $6.71M · Q2 2026
- Morgan Stanley 403.17K sh · $4.43M · Q2 2026
- UBS Group AG 243.15K sh · $2.67M · Q2 2026
- BlackRock Inc 219.92K sh · $2.41M · Q2 2026
- Goldman Sachs Group 155.93K sh · $1.71M · Q2 2026
- Two Sigma Investments 121.00K sh · $1.33M · Q2 2026
- Marshall Wace 72.04K sh · $790.99K · Q2 2026
- Geode Capital Management 29.54K sh · $324.33K · Q2 2026
- Bank of America Corp 25.28K sh · $277.57K · Q2 2026
- Renaissance Technologies 16.93K sh · $185.89K · Q2 2026